COG 133, apolipoprotein peptide fragment (ab269699)
Key features and details
- ApoE peptide mimetic.
- CAS Number: 514200-66-9
- Soluble in DMSO to 100 mM
- Form / State: Solid
- Source: Synthetic
製品の概要
-
製品名
COG 133, apolipoprotein peptide fragment -
製品の詳細
ApoE peptide mimetic. -
生理活性の詳細
ApoE peptide mimetic. Corresponds to amino acids 133-149 of human ApoE. Non-cometitive alpha-7 nicotinic acetylcholine receptor antagonist (IC50 = 445 nM). Inhibits NMDA receptor channel function via interaction with the low-density lipoprotein receptor-related protein. Reduces inflammation, demyleination and cellular infiltration in animal models of multiple sclerosis. Reduces markers of inflammation in 5-fluorouracil model of intestinal mucositis.
-
CAS 番号
514200-66-9 -
構造式
製品の特性
-
分子量
2169.73 -
分子式
C97H181N37O19 -
配列
LRVRLASHLRKLRKRLL -
保存方法
Shipped at room temperature. Store at -20°C. -
溶解性
Soluble in DMSO to 100 mM -
使用に関する注意
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
由来
Synthetic
画像
-
Chemical Structure - COG 133, apolipoprotein peptide fragment (ab269699)
Chemical structure of COG 133, apolipoprotein peptide fragment, 514200-66-9
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (0)
ab269699 は論文での使用が確認できていません。